Digoxin and Triatec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Triatec (ramipril). Common drug interactions include retinopathy of prematurity among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Triatec. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Triatec?

Triatec has active ingredients of ramipril. eHealthMe is studying from 4,133 Triatec users. Check the latest studies of Triatec.



On Jul, 09, 2026

69 people who take Digoxin and Triatec together, and have interactions are studied.

Digoxin and Triatec drug interactions.

What are the common drug interactions of Digoxin and Triatec, by gender? *:

female:

  1. Retinopathy of prematurity (retina damage in premature)
  2. Femur fracture
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Joint dislocation (a joint position is changed from normal position)
  5. Overdose
  6. Renal impairment (severely reduced kidney function)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Cardioactive drug level increased
  9. Blood alkaline phosphatase nos increased
  10. Bradycardia (abnormally slow heart action)

male:

  1. Renal failure acute (rapid kidney dysfunction)
  2. C-reactive protein increased
  3. Blindness unilateral
  4. Blood creatine phosphokinase increased
  5. Blood creatinine increased
  6. Bradycardia (abnormally slow heart action)
  7. Confusion
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Fall
  10. General physical health deterioration (weak health status)

What are the common drug interactions of Digoxin and Triatec, by age (0-1 to 60+)? *:

0-1:

  1. Anuria (failure of the kidneys to produce urine)
  2. Hypotension (abnormally low blood pressure)
  3. Oligohydramnios (a condition in pregnancy characterized by a deficiency of amniotic fluid)
  4. Retinopathy of prematurity (retina damage in premature)
  5. Death
  6. Hydrocephalus (water on the brain)
  7. Intraventricular haemorrhage (intraventricular bleeding)
  8. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
  3. Fatigue (feeling of tiredness)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

40-49:

  1. Arthralgia (joint pain)
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. C-reactive protein increased
  4. Erythrocyte sedimentation rate increased
  5. Hyperplasia (enlargement of an organ or tissue)
  6. Infection
  7. Pain
  8. Pneumonia
  9. Pyrexia (fever)

50-59:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Frequent bowel movements
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Prothrombin level abnormal
  5. Pruritus (severe itching of the skin)
  6. Renal failure (kidney dysfunction)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Reticulocyte count decreased
  9. Skin lesion
  10. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Fall
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Hepatitis (inflammation of the liver)
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Joint dislocation (a joint position is changed from normal position)
  6. Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)
  7. Pain
  8. Renal impairment (severely reduced kidney function)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Cardioactive drug level increased

What are the existing conditions these people have? *

  1. High Blood Pressure: 10 people, 14.49%
  2. Cardiac Failure: 8 people, 11.59%
  3. Neuralgia (pain in one or more nerves): 5 people, 7.25%
  4. Depression: 5 people, 7.25%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Triatec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Digoxin and Triatec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Triatec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Digoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triatec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on digoxin and ramipril (the active ingredients of Digoxin and Triatec, respectively), and Digoxin and Triatec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: